GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common Stock
Rutherford, NJ, April 13, 2023 — GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and prediabetes, today announced the pricing of a firm commitment underwritten public offering of shares of its common stock with gross proceeds to the Company expected to be approximately $10…